港股異動丨速騰聚創暴跌超60%,上市半年禁售期結束
速騰聚創(2498.HK)今日出現暴跌行情,盤中一度跌64%至18.34港元,創上市以來新低,且相較於6月11日創出的上市最高價137.5港元暴跌86%。速騰聚創今年1月5日上市,今早上市半年禁售期完結,逾1816萬股解禁,佔已發行股數4.04%,涉資9.26億港元。公司主要從事開發、生產及銷售用於高級駕駛輔助系統(ADAS)應用以及機器人和其他非汽車行業(如清潔、物流、工業、公共服務及檢驗等)的激光雷達產品,也提供激光雷達感知解決方案和技術開發及其他服務。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.